AI brief of an SEC Form 8-K · CME (CME)

CME Group reports record Q2 2025 revenue of $1.7 billion, up 10% from a year earlier

Positive Impact 3 of 5 earnings Written later

CME Group reported second-quarter 2025 revenue of $1.7 billion, up 10% from the same quarter in 2024, and record average daily volume of 30.2 million contracts, up 16%. Diluted earnings per share were $2.81 on a GAAP basis, compared with $2.42 a year earlier, and $2.96 on an adjusted basis, compared with $2.56.

Key points

  • Q2 2025 revenue of $1.7 billion versus $1.5 billion in Q2 2024; operating income of $1.1 billion
  • Diluted EPS of $2.81 (GAAP) versus $2.42; adjusted diluted EPS of $2.96 versus $2.56
  • Average daily volume of 30.2 million contracts, up 16%; Micros ADV of 4.1 million contracts
  • As of June 30, 2025: $2.2 billion in cash and $3.4 billion of debt; about $3.0 billion in dividends paid in the first six months

The filing

CompanyCME (CME)
Form8-K, current report
Filed with the SECJul 23, 2025, 7:08 AM ET
Accession number0001156375-25-000176

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:21 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 23, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.